Latest Breaking News On - Peterhouse capital limited tel - Page 1 : comparemela.com

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights LONDON, UK / ACCESSWIRE / February 26, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 26 February 2021 consists of 441,378,190 ordinary shares of 1 pence each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 441,378,190. The figure of 441,378,190 ordinary shares may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their investment in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority s Disclosure Guidance and Transparency Rules.

United kingdomCity ofPeter redmondLucy williamsVladislav sandlerCharles goodfellowVadim alexandreDuncan vaseyMatthew johnsonFinancial conduct authority disclosure guidanceSp angel corporate financeLondon stock exchangePeterhouse capital limited telFinancial conduct authorityHemogenyx pharmaceuticalsDisclosure guidance